Home » AstraZeneca Adds Lung-Drug Offerings With Almirall Deal
AstraZeneca Adds Lung-Drug Offerings With Almirall Deal
AstraZeneca, the U.K. drugmaker that resisted a Pfizer Inc. takeover attempt, is building up its respiratory business by buying the rights to Almirall lung medicines for $875 million.
Bloomberg
Bloomberg
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May